122 related articles for article (PubMed ID: 24652690)
1. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.
Zech CJ; Korpraphong P; Huppertz A; Denecke T; Kim MJ; Tanomkiat W; Jonas E; Ba-Ssalamah A;
Br J Surg; 2014 May; 101(6):613-21. PubMed ID: 24652690
[TBL] [Abstract][Full Text] [Related]
2. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.
Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243
[TBL] [Abstract][Full Text] [Related]
3. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.
Litjens G; Rivière DM; van Geenen EJM; Radema SA; Brosens LAA; Prokop M; van Laarhoven CJHM; Hermans JJ
BMC Cancer; 2020 Aug; 20(1):744. PubMed ID: 32778061
[TBL] [Abstract][Full Text] [Related]
5. Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
Ko Y; Kim J; Park JK; Kim H; Cho JY; Kang SB; Ahn S; Lee KJ; Lee KH
PLoS One; 2017; 12(12):e0189797. PubMed ID: 29244853
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
Taylor SA; Mallett S; Beare S; Bhatnagar G; Blunt D; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Miles A; Morris S; Morton A; Navani N; O'Donohue J; Oliver A; Padhani AR; Pardoe H; Patel U; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Shahabuddin K; Sidhu HS; Teague J; Thaha MA; Train M; van Ree K; Wijeyekoon S; Halligan S;
Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):529-537. PubMed ID: 31080095
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic Acid in MRI: A Five-Year Experience at a High-Complexity Hospital in Colombia.
Pimiento Figueroa J; Lopera Valle JS; Gomez Urrego AM; García Gómez V; Gonzalez M; Huertas Duran C
Cureus; 2024 Apr; 16(4):e58150. PubMed ID: 38741819
[TBL] [Abstract][Full Text] [Related]
8. Defining MRI Superiority over CT for Colorectal and Neuroendocrine Liver Metastases.
Attiyeh MA; Malhotra GK; Li D; Manoukian SB; Motarjem PM; Singh G
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894475
[TBL] [Abstract][Full Text] [Related]
9. Liver MRI in patients scheduled for local therapy of colorectal liver metastases.
Vernuccio F
Lancet Oncol; 2024 Jan; 25(1):9-10. PubMed ID: 38081199
[No Abstract] [Full Text] [Related]
10. Enhancing Clinical Decision-Making: The Impact of Liver Contrast-enhanced MRI on Local Treatment Plans for Colorectal Liver Metastases.
Lin YM
Radiol Imaging Cancer; 2024 Jan; 6(1):e239023. PubMed ID: 38240670
[No Abstract] [Full Text] [Related]
11. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
12. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases (Br J Surg 2014; 101: 613-621).
Beets-Tan RG
Br J Surg; 2014 May; 101(6):622. PubMed ID: 24723015
[No Abstract] [Full Text] [Related]
13. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
Vilgrain V; Esvan M; Ronot M; Caumont-Prim A; Aubé C; Chatellier G
Eur Radiol; 2016 Dec; 26(12):4595-4615. PubMed ID: 26883327
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of the liver with gadolinium-ethoxybenzyl-diethylenetriamine penta-acetate-enhanced MRI in living-donor liver transplantation.
Ninomiya M; Shirabe K; Kayashima H; Ikegami T; Nishie A; Harimoto N; Yamashita Y; Yoshizumi T; Uchiyama H; Maehara Y
Br J Surg; 2015 Jul; 102(8):944-51. PubMed ID: 25925288
[TBL] [Abstract][Full Text] [Related]
17. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
[TBL] [Abstract][Full Text] [Related]
18. Consensus report from the 6th International forum for liver MRI using gadoxetic acid.
Sirlin CB; Hussain HK; Jonas E; Kanematsu M; Min Lee J; Merkle EM; Peck-Radosavljevic M; Reeder SB; Ricke J; Sakamoto M
J Magn Reson Imaging; 2014 Sep; 40(3):516-29. PubMed ID: 24923695
[TBL] [Abstract][Full Text] [Related]
19. MRI for characterization of primary tumors in the non-cirrhotic liver: added value of Gd-EOB-DTPA enhanced hepatospecific phase.
Donati OF; Hunziker R; Fischer MA; Raptis DA; Breitenstein S; Patak MA
Eur J Radiol; 2014 Jul; 83(7):1074-1079. PubMed ID: 24816085
[TBL] [Abstract][Full Text] [Related]
20. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Yamashita T; Kitao A; Matsui O; Hayashi T; Nio K; Kondo M; Ohno N; Miyati T; Okada H; Yamashita T; Mizukoshi E; Honda M; Nakanuma Y; Takamura H; Ohta T; Nakamoto Y; Yamamoto M; Takayama T; Arii S; Wang X; Kaneko S
Hepatology; 2014 Nov; 60(5):1674-85. PubMed ID: 24700365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
